dsm-firmenich

Find the latest for dsm-firmenich company news

Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Building mycotoxin-resilient supply chains with AI

Mycotoxins have long been a pervasive challenge in agriculture and food production, threatening both animal and human health. As naturally occurring

Dover's Subsidiary Launches AI-Powered Vehicle Wash Solutions

Dover Corporation DOV announced that its subsidiary Innovative Control Systems, a brand of OPW Vehicle Wash Solutions, launched an AI-powered license-plate recognition (LPR) solution. This move will improve operational efficiency and satisfaction for Dover's customers.

Former Pfizer chief scientist joins Immunai's board of directors

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the appointment of Dr. Mikael Dolsten to its board of directors.

Healthcare 3month
Marico is using AI to map consumer preferences, bring products faster to shelves

Fast-moving consumer Goods (FMCG) maker Marico Ltd. is using Artificial Intelligence in flavour mapping, consumer trend spotting to develop its products and bring them to the market in a shorter time

How pharmaceutical companies are training their workers on AI

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

Telescope advances self-driving lab technology

Telescope Innovations Corp. (CSE:TELI) is leveraging its expertise to advance chemistry process development and crystallization optimization in pharmaceuticals, industrial chemicals, and critical minerals ・Telescope's Self-Driving Labs (SDLs) integrate AI,

Iktos Secures Prestigious EIC Accelerator Grant to Advance its Automated AI and Robotics Platform for Drug Discovery

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.